Posted in | News | Business | Materials Analysis

Microsaic Systems to Showcase New Chip-based Mass Spectrometry Instrument at Pittcon 2013

Microsaic Systems plc, the high technology company developing next generation mass spectrometry instruments, will showcase its new revolutionary chip-based technology for the first time on booth #2255 at PITTCON 2013, from 17-21 March 2013 at the Pennsylvania Convention Center (Philadelphia, PA, USA).

Microsaic Systems is the only producer of mass spectrometry instrumentation using Micro-Electrical-Mechanical Systems (MEMS) technology. The significant and innovative advances in the new chip-based instrument, the Microsaic 4000 MiD, offers a redesigned unit with an even smaller footprint.

Microsaic Systems is the first and only company to have commercialised MS (mass spectrometry) technology on a chip based on MEMS technology originating at the highly regarded Optical and Semiconductor Devices Group at Imperial College London. The Company’s breakthrough product, the 3500 MiD launched in January 2011, represented a step change in the ease of use and footprint of mass spectrometry. The instrument won an R&D 100 award from an independent judging panel and the editors of R&D magazine due to it being smaller, lighter, consuming less energy, easier to maintain and cheaper to run than conventional MS systems.

The Microsaic 4000 MiD is the culmination of over a decade of research, bringing together two high tech fields – chemical analysis and silicon micro-engineering – to make possible a transformative capability in detection. Its low operating cost and small footprint make the instrument deployable in a wide range of applications where mass spectrometry has not been able to reach - until now.

The next generation of the chip-based technology to make its US debut at Pittcon 2013 is now even smaller. As a result the Microsaic 4000 MiD fits even more comfortably into a standard lab fume hood, opening up further opportunities in the field of reaction monitoring. Users are able to increase the use of mass spectrometry in the lab, while benefiting from significant cost savings, owing to fewer necessary structural components such as gas generators and air conditioning. There are also sizeable savings with the use of ‘Plug and Play’ components which enable users to maintain the system themselves, resulting in less downtime and greater flexibility within the laboratory.

“With the premier launch of the Microsaic 4000 MiD and future plans for our growing portfolio of chip-based technology, the Microsaic exhibit at PITTCON will demonstrate how we work with and enable our customers to improve their laboratory operations,” said Colin Jump, CEO, Microsaic Systems. “Offering the smallest footprint in the market, the Microsaic 4000 MiD is a fully integrated, versatile, portable MS system designed for bench chemists. The core technologies are chip-scale versions of traditional mass spec components which can be interchanged rapidly by the user. This modular approach allows users to maintain the system without the need for expensive service contracts and time-consuming call-outs.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Microsaic Systems plc. (2019, February 09). Microsaic Systems to Showcase New Chip-based Mass Spectrometry Instrument at Pittcon 2013. AZoM. Retrieved on November 03, 2024 from https://www.azom.com/news.aspx?newsID=36040.

  • MLA

    Microsaic Systems plc. "Microsaic Systems to Showcase New Chip-based Mass Spectrometry Instrument at Pittcon 2013". AZoM. 03 November 2024. <https://www.azom.com/news.aspx?newsID=36040>.

  • Chicago

    Microsaic Systems plc. "Microsaic Systems to Showcase New Chip-based Mass Spectrometry Instrument at Pittcon 2013". AZoM. https://www.azom.com/news.aspx?newsID=36040. (accessed November 03, 2024).

  • Harvard

    Microsaic Systems plc. 2019. Microsaic Systems to Showcase New Chip-based Mass Spectrometry Instrument at Pittcon 2013. AZoM, viewed 03 November 2024, https://www.azom.com/news.aspx?newsID=36040.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.